TB-500 / Thymosin Beta-4: healing peptide
Medically reviewed by: Op. Dr. Ferhat İlen, ENT – Head & Neck Surgeon · Last updated:
Thymosin Beta-4 is a natural protein regulating actin dynamics within cells; TB-500 is a synthetic fragment derived from it. Animal models demonstrate findings related to wound, cardiac, and muscle repair.
Regulatory / evidence status: Not approved as a medication; listed on FDA safety alerts and banned by WADA.
Level of evidence
Eye drop and wound gel formulations of Thymosin Beta-4 have been evaluated in early clinical trials. There are no controlled human trials evaluating the TB-500 fragment.
Risks
Due to its potential to promote cell migration and angiogenesis, caution is warranted in patients with a history of malignancy; product purity cannot be verified.
Frequently asked questions
Can it be combined with BPC-157?
This combination is popular; however, its efficacy and safety have not been established in humans.
References
This page is for information only and does not replace diagnosis, treatment advice or a prescription. Peptide and drug assessments are made only after a physician consultation. No results are guaranteed.
Ask your physician whether it is right for you